Pfizer-BioNTech COVID-19 mRNA vaccine
PreclinicalVaccine
PfizerPfizer-BioNTech COVID-19 mRNA vaccine is one of 15 biologic programs targeting COVID-19. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
14
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
317 competitors in COVID-19
#DrugCompanyPhaseTrials
1Blood Taken
HHospices Civils de Lyon
Preclinical
Other Tkis
BayerPreclinical
Serology
UUniversity Hospital Center of Martinique
Preclinical
Huashi Baidu Granule
XXiyuan Hospital of China Academy of Chinese Medical Sciences
Preclinical
Administration of Almitrine
CCentre Hospitalier Universitaire de Nice
Preclinical
Tpa
UUniversity of Florida
Preclinical
Thrombolytic
FFaculty Hospital Kralovske Vinohrady
Preclinical
Coronavac COVID-19 Vaccine
HHospital Moinhos de Vento
Preclinical
SARS-Cov-2 Bivalent MRNA Vaccine
AAIM Vaccine Co., Ltd.
Preclinical
Serological Test
CCentre Hospitalier de Cornouaille
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]